Why Your GLP-1 Provider Should Be Checking Your Testosterone

GLP-1 medications can raise testosterone by 18% in men with obesity. But most telehealth providers aren't monitoring it — which means you're potentially missing one of the biggest benefits of your treatment.

Published May 1, 2026 · Last verified May 1, 2026

Here's something most GLP-1 telehealth providers won't tell you: the medication you're taking for weight loss may also be treating your low testosterone. Not as a side effect — as a direct downstream consequence of reducing the visceral fat that was suppressing your hormones in the first place.

The problem is that if nobody's checking your levels, you'll never know. And if your testosterone is rising naturally, you might not need the TRT prescription you've been considering. Or you might discover that despite significant weight loss, your testosterone hasn't budged — a finding that would change your treatment approach entirely.

The Data: GLP-1s Are Raising Testosterone in Obese Men

Multiple studies published in 2025 and 2026 now confirm what endocrinologists suspected: GLP-1-driven weight loss consistently improves testosterone levels in men with obesity-related hypogonadism.

A 2024 Slovenian randomized controlled trial comparing semaglutide to TRT in obese diabetic men with hypogonadism found that semaglutide with 6.5% weight loss produced a comparable increase in total testosterone to TRT itself — while also delivering superior body composition improvements. A 2025 Italian pilot study went further: tirzepatide produced larger increases in both free and total testosterone than transdermal TRT over 8 weeks, plus better erectile function scores.

A November 2025 systematic review in the Journal of Sexual Medicine, analyzing 23 studies on GLP-1 agonists and testosterone, concluded that these medications show consistent associations with improved hormonal profiles in men with metabolic dysfunction. A separate 2025 meta-analysis in BMC Urology reached a similar conclusion.

A 2026 study further confirmed that GLP-1 receptor agonists may improve both testosterone levels and semen quality in men with metabolic issues — suggesting the benefits extend beyond hormonal numbers into actual reproductive function.

Why This Matters: The Monitoring Gap

Most GLP-1 telehealth programs are designed around a simple funnel: intake questionnaire, BMI check, prescribe, ship. The focus is weight loss metrics — pounds lost, waist circumference, maybe a metabolic panel. Testosterone monitoring is almost never included in the standard protocol.

This creates two problems:

Problem 1: Missed natural recovery. If your testosterone is climbing due to GLP-1-driven fat loss, you might avoid TRT entirely — saving hundreds per month and avoiding the fertility implications that come with exogenous testosterone. But if no one checks, you won't know.

Problem 2: Missed non-responders. Not all men with obesity-related low T fully recover testosterone through weight loss alone. Individual variation is significant. Some men lose substantial weight but their T remains low, indicating primary hypogonadism that requires direct treatment. Without monitoring, these men continue to suffer symptoms they attribute to "still adjusting to the medication."

The Mechanism: Why Losing Fat Raises Testosterone

The relationship between visceral fat and testosterone is bidirectional and well-established. Excess visceral fat — the metabolically active fat surrounding your organs — contains high concentrations of aromatase, the enzyme that converts testosterone to estrogen. More visceral fat means more aromatization, which means lower circulating testosterone and higher estradiol.

GLP-1 medications preferentially reduce visceral fat. As this fat decreases, aromatase activity drops, and testosterone levels can rise naturally. The process is gradual — most studies show meaningful testosterone improvements starting around 3–6 months of consistent weight loss — but the effect is real and measurable.

This is also why the degree of fat loss matters more than the specific medication. Evidence suggests testosterone improvements correlate with the percentage of body fat lost rather than which GLP-1 you're taking. Tirzepatide, which typically produces greater weight loss than semaglutide, tends to show larger testosterone improvements — likely because of greater fat reduction rather than any direct hormonal mechanism.

When TRT Is Still Needed

GLP-1-driven testosterone recovery has limits. It works best for functional (obesity-related) hypogonadism, where excess fat is the primary driver of low T. It does not work for primary hypogonadism (testicular failure) or for men whose testosterone was already low before weight gain.

Key scenarios where TRT may still be necessary even on a GLP-1:

Sustained low T despite significant weight loss: If you've lost 10%+ body weight over 6+ months and total testosterone remains below 300 ng/dL, weight loss alone isn't resolving it.

Elevated LH with low testosterone: This pattern suggests the testes aren't responding to hormonal signals — a primary testicular issue that weight loss won't fix.

Pre-existing low T before obesity: If your testosterone was already low in your 20s or early 30s before significant weight gain, the mechanism isn't aromatization, and weight loss is unlikely to resolve it.

Providers That Get This Right

Look for GLP-1 providers that either include hormonal monitoring in their protocols or make it easy to add. The best programs offer comprehensive lab work that goes beyond basic metabolic panels.

Compounded medications are not FDA-approved. Consult your provider about appropriate lab monitoring.

The Bottom Line

GLP-1 medications are producing meaningful testosterone improvements in men with obesity — improvements that rival or sometimes exceed TRT in the right population. But testosterone monitoring isn't standard practice at most telehealth providers, which means many men are missing one of the most significant health benefits of their treatment.

If you're a man over 35 on a GLP-1 medication, request baseline testosterone labs before or early in treatment, and follow-up labs at 3–6 months. It's a simple blood draw that could fundamentally change how you and your provider approach your total health — not just your weight.

Affiliate Disclosure: Some provider links on this page are affiliate links. If you sign up through these links, we may receive compensation at no additional cost to you. This does not influence our editorial content or provider selection.